Jump to content

Norelgestromin/ethinylestradiol

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 04:25, 27 September 2018. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Norelgestromin/ethinylestradiol
Combination of
EthinylestradiolEstrogen
NorelgestrominProgestogen
Clinical data
Trade namesOrtho Evra, Xulane
MedlinePlusa602006
License data
Routes of
administration		Transdermal (patch)
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
  • None
KEGG
Main article: Contraceptive patch

Ethinylestradiol/norelgestromin (brand names Ortho Evra, Evra, Xulane) is a contraceptive patch containing the estrogen ethinylestradiol and the progestin norelgestromin which is marketed in the United States, Canada, Europe, and elsewhere in the world.[1][additional citation(s) needed] As of December 2016, the Ortho Evra product has been discontinued in the U.S. while the Xulane product continues to be marketed in this country.[1]

See also

References

  1. ^ a b "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 22 December 2016.


Stub icon

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Norelgestromin/ethinylestradiol&oldid=861401891"